adenosine 2',3'-ribo-epoxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 72252 |
| CHEMBL ID | 2032007 |
| SCHEMBL ID | 5471536 |
| MeSH ID | M0048959 |
| Synonym |
|---|
| 2',3'-epoxya down |
| 2',3'-epoxyadenosine down |
| 2627-64-7 |
| [(1r,2r,4r,5r)-4-(6-aminopurin-9-yl)-3,6-dioxabicyclo[3.1.0]hexan-2-yl]methanol |
| CHEMBL2032007 |
| adenosine, 2',3'-anhydro- |
| adenosine 2',3'-ribo-epoxide |
| 9-(2,3-anhydro-beta-d-ribofuranosyl)adenine |
| 2',3'-anhydroadenosine |
| SCHEMBL5471536 |
| RANSNKOSWWZYEJ-KQYNXXCUSA-N |
| A855616 |
| 9-(2,3-anhydropentofuranosyl)-9h-purin-6-amine |
| DTXSID70949134 |
| [(1r,2r,4r,5r)-4-(6-amino-9h-purin-9-yl)-3,6-dioxabicyclo[3.1.0]hexan-2-yl]methanol |
| ((1r,2r,4r,5r)-4-(6-amino-9h-purin-9-yl)-3,6-dioxabicyclo[3.1.0]hexan-2-yl)methanol |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID662565 | Growth inhibition of Trichomonas vaginalis T1 at 100 uM after 24 hrs by hemocytometry | 2012 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12 | S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,D-arabinofuranosyl)adenine. |
| AID1065714 | Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E after 72 hrs by WST-1 assay | 2013 | Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24 | Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. |
| AID81438 | Dose required to inhibit cytopathic effect of human immunodeficiency virus replication in MT-4 cells. | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10 | Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. |
| AID81069 | Cytotoxic dose required to reduce the viability of normal uninfected MT-4 cells. | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10 | Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||